Featured Research

from universities, journals, and other organizations

Rice Uses Buckyballs To Reinvent 'Antibiotic Of Last Resort'; New Drug Could Become First Targeted Antibiotic, New Defense Against Bioterrorism

Date:
April 18, 2003
Source:
Rice University
Summary:
Rice University chemists hope a new variant of vancomycin that contains buckyballs -- tiny cage-shaped molecules of pure carbon -- could become the world's first targeted antibiotic, creating a new line of defense against bioweapons like anthrax.

HOUSTON, April 17, 2003 -- Rice University chemists hope a new variant of vancomycin that contains buckyballs -- tiny cage-shaped molecules of pure carbon -- could become the world's first targeted antibiotic, creating a new line of defense against bioweapons like anthrax.

Related Articles


Vancomycin, which entered clinical service 40 years ago, is the antibiotic of last resort, given only when all others fail. Unfortunately, vancomycin-resistant strains of bacteria have appeared in recent years.

In an effort to reinvigorate vancomycin, researchers have created vancomycin conjugates -- pairs of vancomycin molecules joined by an intermediate molecule that acts as a bridge -- some of which have proven more effective at killing resistant bacteria.

Rice Chemistry Professor Lon Wilson decided to create a buckyball-vancomycin conjugate following years of work developing biochemical targeting mechanisms for buckyballs, spherical cages containing 60 carbon molecules. By linking antibodies to a buckyball with anticancer drugs attached to it, Wilson and two of his graduate students, Tatiana Zakharian and Jared Ashcroft, are creating targeted compounds that will bind only with certain cells, like those found in melanoma tumors, for example.

"Having the ability to target antibiotics to attack specific bacterial antigens opens the door for treatments that simply aren't available today," said Wilson. "For example, we believe it's feasible to create a C60-vancomycin conjugate that attaches to anthrax while it is still in the spore form."

Weaponized anthrax is delivered in spores, a dormant form in which the disease is encased in a rugged shell. Once the spore finds its way into a living host, it germinates and becomes active.

Wilson said vancomycin can attack anthrax only after it germinates. However, having the ability to affix the antibiotic to a spore could enable the drug to knock the disease out when it tries to emerge from hibernation, before it has a chance to spread throughout the body and release its toxins.

A postdoctoral fellow in Wilson's lab, Dr. Andrey Mirakyan, recently presented preliminary results of the work at this spring's American Chemical Society annual meeting and they expect to publish research findings soon.

This research was sponsored by the Welch Foundation.


Story Source:

The above story is based on materials provided by Rice University. Note: Materials may be edited for content and length.


Cite This Page:

Rice University. "Rice Uses Buckyballs To Reinvent 'Antibiotic Of Last Resort'; New Drug Could Become First Targeted Antibiotic, New Defense Against Bioterrorism." ScienceDaily. ScienceDaily, 18 April 2003. <www.sciencedaily.com/releases/2003/04/030418081522.htm>.
Rice University. (2003, April 18). Rice Uses Buckyballs To Reinvent 'Antibiotic Of Last Resort'; New Drug Could Become First Targeted Antibiotic, New Defense Against Bioterrorism. ScienceDaily. Retrieved January 28, 2015 from www.sciencedaily.com/releases/2003/04/030418081522.htm
Rice University. "Rice Uses Buckyballs To Reinvent 'Antibiotic Of Last Resort'; New Drug Could Become First Targeted Antibiotic, New Defense Against Bioterrorism." ScienceDaily. www.sciencedaily.com/releases/2003/04/030418081522.htm (accessed January 28, 2015).

Share This


More From ScienceDaily



More Matter & Energy News

Wednesday, January 28, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

'Brand Blocker' Glasses Blur Ads in Real Time

'Brand Blocker' Glasses Blur Ads in Real Time

Buzz60 (Jan. 28, 2015) A team of college students design and build a pair of goggles that will obscure any corporate branding from your field of vision. Jen Markham (@jenmarkham) has the story. Video provided by Buzz60
Powered by NewsLook.com
Amplifying Tiny Movements to Visualize the Invisible

Amplifying Tiny Movements to Visualize the Invisible

Reuters - Innovations Video Online (Jan. 28, 2015) A new video recording method that amplifies seemingly invisible motion could lead to a touch-free vital signs monitor, and offer a new tool for engineers to gauge stresses on bridges and tunnels in real time. Ben Gruber reports. Video provided by Reuters
Powered by NewsLook.com
Boeing's Profit Soars

Boeing's Profit Soars

Reuters - Business Video Online (Jan. 28, 2015) Boeing delivered more commercial planes, especially 737s and 787s, fueling profit. But it issued a mixed outlook. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Robot Replacements for Foxconn's Workers

Robot Replacements for Foxconn's Workers

Reuters - Business Video Online (Jan. 28, 2015) Foxconn parent Hon Hai Precision Industry is looking to automation to keep productivity up without the rising costs of human labor. Meg Teckman reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Space & Time

Matter & Energy

Computers & Math

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins